United States - English - NLM (National Library of Medicine)

zydus lifesciences limited - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil  tablets,usp are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets, usp are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets, usp are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets, usp are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil beyond 26 weeks is unknown [see clinical studies (14.3) ]. administration of tadalafil to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil. hypersensitivity reacti

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals limited - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets usp are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets usp are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets usp are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets usp are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets usp decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets usp beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity t

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets usp are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets usp are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets usp are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets usp are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets usp decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets usp beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity t

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil  tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil beyond 26 weeks is unknown [see clinical studies (14.3) ]. administration of tadalafil to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil. hypersensitivity reactions have been repor

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablet is indicated for the treatment of erectile dysfunction (ed). tadalafil tablet is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablet is indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablet is used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)]. tadalafil tablet is contraindicated in patients with a known serious hypersensitivity to tadalafil (tadalafil tablets or ad

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablet is indicated for the treatment of erectile dysfunction (ed). tadalafil tablet is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablet is indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablet is used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)]. tadalafil tablet is contraindicated in patients with a known serious hypersensitivity to tadalafil (tadalafil tablets or ad

United States - English - NLM (National Library of Medicine)

macleods pharmaceuticals limited - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3) ]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)]. tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (tadalafil ta

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decrease from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies ( 14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [ see clinical pharmacology ( 12.2) ]. tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (or a

United States - English - NLM (National Library of Medicine)

proficient rx lp - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil or adcirca®

United States - English - NLM (National Library of Medicine)

proficient rx lp - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decrease from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2) ]. tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (or adcirca® ). hypers